Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP621399.RAAULfT8JBEV6MgnxywhSAtgGQJUROkbhsAUJbd-UQGVQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP621399.RAAULfT8JBEV6MgnxywhSAtgGQJUROkbhsAUJbd-UQGVQ130_assertion type Assertion NP621399.RAAULfT8JBEV6MgnxywhSAtgGQJUROkbhsAUJbd-UQGVQ130_head.
- NP621399.RAAULfT8JBEV6MgnxywhSAtgGQJUROkbhsAUJbd-UQGVQ130_assertion description "[HIF-1 is also activated in cancer cells by tumor suppressor (e.g., VHL) loss of function and oncogene gain of function (leading to PI3K/AKT/mTOR activity) and mediates metabolic alterations that drive cancer progression and resistance to therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP621399.RAAULfT8JBEV6MgnxywhSAtgGQJUROkbhsAUJbd-UQGVQ130_provenance.
- NP621399.RAAULfT8JBEV6MgnxywhSAtgGQJUROkbhsAUJbd-UQGVQ130_assertion evidence source_evidence_literature NP621399.RAAULfT8JBEV6MgnxywhSAtgGQJUROkbhsAUJbd-UQGVQ130_provenance.
- NP621399.RAAULfT8JBEV6MgnxywhSAtgGQJUROkbhsAUJbd-UQGVQ130_assertion SIO_000772 23999440 NP621399.RAAULfT8JBEV6MgnxywhSAtgGQJUROkbhsAUJbd-UQGVQ130_provenance.
- NP621399.RAAULfT8JBEV6MgnxywhSAtgGQJUROkbhsAUJbd-UQGVQ130_assertion wasDerivedFrom befree-20150227 NP621399.RAAULfT8JBEV6MgnxywhSAtgGQJUROkbhsAUJbd-UQGVQ130_provenance.
- NP621399.RAAULfT8JBEV6MgnxywhSAtgGQJUROkbhsAUJbd-UQGVQ130_assertion wasGeneratedBy ECO_0000203 NP621399.RAAULfT8JBEV6MgnxywhSAtgGQJUROkbhsAUJbd-UQGVQ130_provenance.